The Campbell, California-based stroke treatment developer now stands as the parent company of four businesses. These businesses all share a common goal of bringing care to those affected by stroke and other ischemic diseases.
According to a news release, the entities under the Imperative Care umbrella include Imperative Care Stroke, Imperative Care Vascular, Kandu Health and Telos Health.
Imperative Care Stroke aims to bring life-saving interventional treatments to patients with ischemic and hemorrhagic stroke. Imperative Care Vascular — formerly Truvic Medical, acquired in 2021 — aims to advance treatments for vascular diseases. These include pulmonary embolism.
Kandu Health, a digital health company, aims to change the course of stroke recovery and post-acute care through remote support. Telo Health utilizes robotics and automation to optimize vascular intervention. It aims to make life-saving stroke and vascular thrombectomies accessible to more people.
“Our vision for Imperative Care has always been to bring forward clinically meaningful innovations that are inspired and shaped by physicians and unmet clinical needs impacting patient care,” said Fred Khosravi, chair and CEO of Imperative Care. “We believe that the patient is the only constant in the chain of care from detection through treatment and recovery. Through connected innovation, we can look holistically at what the patient needs across the full continuum of care and achieve something meaningful for patients and their families.”
More about Imperative Care and its new business units
The company’s stroke business develops the Zoom stroke solution product platform, designed to usher in a new era of stroke thrombectomy. It enables fast and consistent treatment, plus improved procedure outcomes. Through reperfusion, physicians can perform fast, effective clot removal in patients with ischemic stroke. Zoom aims to help complete clot removal and full reperfusion of the target vessel within 10 minutes.
Imperative Care Vascular currently has two FDA-cleared products: the Symphony and Prodigy thrombectomy systems. Symphony offers venous applications and Prodigy offers peripheral arterial applications. The company already made Prodigy available at select U.S. hospitals, while it plans for a targeted launch for Symphony in the coming months.
Kandu Health became an independent company earlier this year and remains a majority-owned business of Imperative Care. Its digital health platform offers stroke survivors remote clinical support within the first 90 days following a stroke. It tailors its support to each participant based on individual needs.
Telos Health expects to dramatically expand access to thrombectomy care, the company said. It has the goal of improving treatment speed, procedural consistency and outcomes.
“Through our businesses and development programs, we are building a portfolio of connected innovations that tangibly elevate care for patients, resulting in durable growth into the back half of this decade, and for decades to come,” said Matthew Garrett, Imperative Care CFO. “Every day, this purpose-built company is one step closer to making this vision a reality.”
